Norethindrone-d8
Norethindrone-d8 (Norethisterone-d8) is deuterium labeled Norethindrone. Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.
Product Specifications
Product Name Alternative
Norethisterone-d8
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Cancer
Smiles
C[C@@]12[C@](CC([2H])([2H])[C@@]2(O)C#C)([H])[C@@]3([H])[C@]([C@]4([2H])C(C([2H])([2H])C3)=C([2H])C(C([2H])([2H])C4)=O)([H])CC1
Molecular Formula
C20H18D8O2
Molecular Weight
306.47
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![N-[1,1′-Biphenyl]-4-ylbenzo[b]naphtho[1,2-d]furan-9-amine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
ALPL (Alkaline phosphatase liver/bone/kidney isozyme) (HRP)
